Several studies have demonstrated that of all B-cell-stimulating factors, interleukin (IL)-6 plays the most important role in MM by regulating the growth and survival of the neoplastic cells (Kawano et al, 1988; Klein et al, 1995; Cote et al, 2002). Here, IL6 is linked to Miyoshi myopathy.